SCL Balance Sheet - SLB NV

Watchlist Manager

Watchlist

Price: 46.02 EUR -0.44% Market Closed

Market Cap: €39.7B

S	SLB NV XMUN:SCL	US
E	Exor NV SWB:EYX	NL
S	SLB NV DUS:SCL	US
C	Clicks Group Ltd JSE:CLS	ZA
	Mitsui O.S.K. Lines Ltd OTC:MSLOF	JP
N	Nabors Industries Ltd F:NBI1	BM
T	Thermo Fisher Scientific Inc BMV:TMO	US
E	Exor NV VSE:EXO	NL

Financial profile · Q3 FY2026

Cash-generative scale with cyclical margins and acquisition-shaped comparisons

SLB’s multiyear record shows revenue expansion and margin improvement through 2024, followed by some easing, alongside recurring positive free cash flow. The ChampionX acquisition broadened reported revenue and makes comparisons more acquisition-sensitive, without changing the underlying pattern of cash generation.

What is developing

The latest quarter showed revenue growth both sequentially and year over year, while operating income and common earnings remained below the year-earlier quarter. That combination suggests a sequential recovery without yet reversing the recent margin pressure.

What matters next

Whether revenue recovery is accompanied by sustained improvement in operating margin.

Metric	FY2016 Dec 2016	FY2017 Dec 2017	FY2018 Dec 2018	FY2019 Dec 2019	FY2020 Dec 2020	FY2021 Dec 2021	FY2022 Dec 2022	FY2023 Dec 2023	FY2024 Dec 2024	FY2025 Dec 2025
Cash & Cash Equivalents	2.9B	1.8B	1.4B	1.1B	844m	1.8B	1.7B	2.9B	3.5B	3B
Cash	2.9B	1.8B	1.4B	1.1B	844m	1.8B	1.7B	2.9B	3.5B	3B
Short-Term Investments	6.3B	3.3B	1.3B	1B	2.2B	1.4B	1.2B	1.1B	1.1B	1.2B
Total Receivables	9.4B	8.1B	7.9B	7.7B	5.2B	5.3B	7B	7.8B	8B	8.7B
Accounts Receivables	9.4B	8.1B	7.9B	7.7B	5.2B	5.3B	7B	7.8B	8B	8.7B
Other Receivables	0	0	0	0	0	0	0	0	0	0
Inventory	4.2B	4B	4B	4.1B	3.4B	3.3B	4B	4.4B	4.4B	5B
Other Current Assets	1.1B	1.3B	1.1B	1.5B	1.3B	928m	1.1B	1.5B	1.5B	1.6B
Total Current Assets	23.9B	18.5B	15.7B	15.5B	12.9B	12.7B	15B	17.7B	18.6B	19.5B
PP&E Net	12.8B	11.6B	13.5B	10.6B	7.6B	7B	6.6B	7.2B	7.4B	7.9B
PP&E Gross	12.8B	11.6B	13.5B	10.6B	7.6B	7B	6.6B	7.2B	7.4B	7.9B
Accumulated Depreciation	(27.2B)	(26.2B)	(27B)	(25.7B)	(22.9B)	(22.6B)	(21.8B)	(22.7B)	(22.2B)	(24.2B)
Intangible Assets	9.9B	9.4B	8.7B	7.1B	3.5B	3.2B	3B	3.2B	3B	5B
Goodwill	25B	25.1B	24.9B	16B	13B	13B	13B	14.1B	14.6B	16.8B
Long-Term Investments	1.5B	1.5B	1.5B	1.6B	2.1B	2B	1.6B	1.6B	1.6B	1.8B
Other Long-Term Assets	4.9B	5.9B	6.1B	5.5B	3.4B	3.6B	4B	4.1B	3.8B	3.9B
Other Assets	25B	25.1B	24.9B	16B	13B	13B	13B	14.1B	14.6B	16.8B
Total Assets	78B	72B	70.5B	56.3B	42.4B	41.5B	43.1B	48B	48.9B	54.9B
Accounts Payable	3.9B	4.6B	4.7B	4.8B	2.9B	3.2B	3.9B	4.6B	4.2B	4.9B
Accrued Liabilities	1.3B	1.3B	1.8B	1.8B	1.8B	1.6B	1.7B	1.8B	1.7B	2.3B
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	3.2B	3.3B	1.4B	524m	850m	909m	1.6B	1.1B	1.1B	1.9B
Other Current Liabilities	6.6B	6B	5.6B	6B	4.9B	4.7B	4.8B	5.8B	5.9B	5.7B
Deferred Revenue	1.1B	752m	877m	910m	941m	1.1B	1.2B	2B	2B	2.3B
Total Current Liabilities	15.1B	15.3B	13.5B	13.1B	10.5B	10.4B	12B	13.4B	12.8B	14.7B
Long-Term Debt	16.5B	14.9B	14.6B	14.8B	16B	13.3B	10.6B	10.8B	11B	9.7B
Deferred Income Tax	1.9B	1.7B	1.4B	491m	19m	94m	61m	140m	67m	644m
Minority Interest	451m	419m	424m	416m	418m	282m	304m	1.2B	1.2B	1.2B
Other Liabilities	3B	2.9B	4.4B	3.8B	3.4B	2.5B	2.5B	2.2B	2.7B	2.5B
Total Liabilities	36.9B	35.1B	34.3B	32.6B	30.4B	26.5B	25.5B	27.8B	27.8B	28.8B
Common Stock	12.8B	13B	13.1B	13.1B	13B	12.6B	11.8B	11.6B	11.5B	16.4B
Retained Earnings	36.5B	32.2B	31.7B	18.8B	7B	8.2B	10.7B	13.5B	16.4B	18.1B
Unrealized Security Profit/Loss	21m	13m	2m	2m	2m	0	—	—	—	—
Treasury Stock	(3.6B)	(4B)	(4B)	(3.6B)	(3B)	(2.2B)	(1B)	(678m)	(1.8B)	(3.6B)
Other Equity	(4.7B)	(4.3B)	(4.6B)	(4.4B)	(4.9B)	(3.6B)	(3.9B)	(4.3B)	(5B)	(4.7B)
Total Equity	41.1B	36.8B	36.2B	23.8B	12.1B	15B	17.7B	20.2B	21.1B	26.1B
Total Liabilities & Equity	78B	72B	70.5B	56.3B	42.4B	41.5B	43.1B	48B	48.9B	54.9B
Common Shares Outstanding	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.5B